|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. REFERENCESBates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. 1995a. Relationship between medication errors and adverse drug events. Journal of General Internal Medicine 10(4): 100–205. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, Vander Vliet M, Nemeskal R, Leape LL. 1995b. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. Journal of the American Medical Association 274:29–34. FDA (U.S. Food and Drug Administration). 2004. Drugs @ FDA: Glossary of Terms. [Online]. Available: http://www.fda.gov/cder/drugsatfda/glossary.htm [accessed June 7, 2005]. FDA. 2005. Office of Nonprescription Drugs. [Online]. Available: http://www.fda.gov/cder/ offices/otc/default.htm [accessed June 7, 2005]. Gandhi TK, Seger DL, Bates DW. 2000. Identifying drug safety issues: From research to practice. International Journal for Quality in Health Care 12(1):69–76. IOM (Institute of Medicine). 1996. Primary Care: America’s Health in a New Era. Washington, DC: National Academy Press. IOM. 2004. Patient Safety: Achieving a New Standard for Care. Washington, DC: The National Academies Press.
|
|
|||||||||||||||
